Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06916052

Study to Analyse the Use of a Digital Platform for the Preparation and Follow-up of Patients With Scheduled Outpatients Colonoscopy

The goal of this clinical trial investigation with device is to to analyze the use of the Caaring® digital platform for the preparation and follow-up of scheduled colonoscopy.

Colonoscopy is a difficult procedure, and it is estimated that bowel preparation is inadequate in about 25% of patients. The main question it aims to answer is if the use of a digital platform (Caaring®) could be an effective tool for reducing the percentage of inadequate bowel preparations in patients with a scheduled colonoscopy. To this end, the application will provide precise instructions to patients.

A prospective, single-center, observational study with software device: The recruitment phase is expected to last two months. Patients will be followed for one month after the colonoscopy and 14 days prior to it.

Additionally, measuring patient experience and monitoring adverse effects after a colonoscopy are crucial to improving the safety of colonoscopies and the quality of healthcare, promoting higher quality colonoscopy services.

For that to happen, participants must have sufficient technological skills to use a smartphone.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Hospital Clínic de Barcelona

Barcelona, 08036, Spain

Location status: Recruiting

Location contact

Francesc Balaguer Prunés, PhD

CONTACT

[email protected]

+34932275400

About this study

A prospective, single-center, observational study with software device. The protocol and informed consent documents have been reviewed and approved by the hospital human subjects reviewboard and the study will be performed in accordance with the Declaration of Helsinki.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18 or older.
  • Signed informed consent.
  • Patients scheduled for outpatient colonoscopy.
  • Patients able to complete the study questionnaires.
  • Patients who regularly use a smartphone

Exclusion criteria

  • Patients enrolled in the population-based colorectal cancer screening program with a positive fecal occult blood test.
  • Minors or elderly patients (over 80 years of age).
  • Patients with prior colorectal surgery.
  • Patients who, in the opinion of the researcher, will not be able to commit to follow-up or lack adequate technological skills.
  • Inability to provide adequate informed consent.

Treatment and study plan

Primary outcomes

  1. Percentage of patients scheduled colonoscopy who have an adequate bowel preparation.

    Time frame: Day 0, (Colonoscopy Day)

    Percentage of colonoscopies with adequate bowel preparation defined as having a total Boston Bowel Preparation Scale (BBPS) score greater than or equal of 6 and BBPS score for per colon segment ≥2.

Secondary outcomes

  1. Active Patient Rate

    Time frame: Day -14 (14 days before the colonoscopy)

    Active patient rate defined as the number of patients who activate their account divided by the total number of patients guests.

  2. Patients with section completed: Treatments

    Time frame: Day -14 (14 days before the colonoscopy)

    Of active patients, percentage who completes the section Treatments

  3. Patients with section completed: Pick up the bowel preparation

    Time frame: Day -10 (10 days before colonoscopy)

    Of active patients, percentage who completes the section Pick up the bowel preparation.

  4. Patients with section completed: Colonoscopy Preparation Solution (laxative).

    Time frame: Day 2 (2 days after colonoscopy)

    Of active patients, percentage who completes the secion Colonoscopy Preparation Solution (laxative).

  5. Patients with section completed: Procedure satisfaction questionnaire

    Time frame: Day 3 (3 days after colonoscopy)

    Of active patients, percentage who completed the section Procedure satisfaction questionnaire.

  6. Patients with section completed: Adverse Events

    Time frame: Day 1, Day 14 and Day 30

    Of active patients, percentage of patients who completes the Adverse Events section.

  7. Percentage of patients with 100% of data completed

    Time frame: Day 31 (31days after the colonoscopy)

    Percentage of patients with 100% of data completed in the application.

  8. Patients who view educational materials: Pick up the laxative

    Time frame: Day -10 (10 days before colonoscopy)

    Of active patients, percentage of Patients who view the educational materials: Pick up the laxative. The app will reflect the date and time that patients viewed that information.

  9. Patients who view educational materials: Diet

    Time frame: Day -4 (4 days before colonoscopy)

    Of active patients, percentage of Patients who view the educational material: Diet. The app will reflect the date and time that patients viewed that information.

  10. Patients who view educational materials: Adequate preparation for a colonoscopy

    Time frame: Day -4 (4 days before colonoscopy)

    Of active patients, percentage of Patients who view the educational material: Adequate preparation for a colonoscopy . The app will reflect the date and time that patients viewed that information.

  11. Patients who view educational materials: Bring someone

    Time frame: Day -4 (4 days before colonoscopy)

    Of active patients, percentage of Patients who view the educational material: bring someone. The app will reflect the date and time that patients viewed that information.

  12. Patients who view educational materials: Instructions for your colonoscopy

    Time frame: Day -3 (3 days before colonoscopy)

    Of active patients, percentage of Patients who view the educational material: Instructions for your colonoscopy. The app will reflect the date and time that patients viewed that information.

  13. Percentage of patients with 100% of education materials viewed.

    Time frame: Day 31 (31days after the colonoscopy)

    Percentage of patients with 100% of educational materials viewed in the application.

  14. Percentage of patients who take the laxative

    Time frame: Day -3 (3 days before the colonoscopy)

    Percentage of patients who take the laxative.

  15. Patient satisfaction with the bowel preparation (laxative)

    Time frame: Day 2 (2 days after colonoscopy)

    The patient satisfaction with the bowel preparation will be measured through a specific satisfaction questionnaire created for this purpose. (Value 1-4). A higher score reflects greater satisfaction with software care.

  16. Patient satisfaction with the colonoscopy experience

    Time frame: Day 3 (3 days after colonoscopy)

    The patient satisfaction with the colonoscopy experience will be measured through a specific satisfaction questionnaire created for this purpose. (Value 1-5). A higher score reflects greater satisfaction with software care.

Study contacts

Contact information is provided by the study sponsor or research team.

Roberto Bravo

CONTACT

[email protected]

+34 915004013

Sponsors and collaborators

Lead sponsor

Persei Vivarium

Other

Collaborators

  • Effice Servicios Para la Investigacion S.L.

Registry information

Official study title

An Observational Study of the Digital Platform Use for the Preparation and Monitoring of Patients With Scheduled Outpatient Colonoscopy

Acronym: COLObs

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Apr 8, 2025
Registry last updated
Jun 15, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.